McKesson | MCK - Selling And Administration Expenses

Stock Price
747.23
Daily Change
10.05 1.36%
Monthly
-13.46%
Yearly
5.73%
Q2 Forecast
720.85

McKesson reported $1.8B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Acadia Healthcare USD 82.69M 3.6M Mar/2026
Align Technology USD 465.34M 23.67M Mar/2026
Cardinal Health USD 1.51B 6M Mar/2026
Centene USD 3.4B 27M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cigna USD 3.32B 291M Mar/2026
Community Health Systems USD 10.13B 32.48B Mar/2026
Computer Programs Systems USD 51.62M 109.74M Dec/2025
DaVita Healthcare Partners USD 421.91M 50.45M Mar/2026
Dentsply International USD 351M 32M Mar/2026
eHealth USD 69.42M 70.12M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
Encompass Health USD 58.2M 10.2M Mar/2026
HCA USD 39.49B 116.72B Mar/2026
Henry Schein USD 809M 1000K Mar/2026
Humana USD 3.36B 614M Mar/2025
IQVIA Holdings USD 502M 34M Mar/2026
J&J USD 6.03B 719M Mar/2026
Laboratory Of America USD 551M 12.4M Mar/2026
McKesson USD 1.8B 234M Mar/2026
Molina Healthcare USD 3.77B 2.43B Mar/2026
Owens Minor USD 258.98M 7.5M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Stryker USD 2.15B 17M Mar/2026
Tenet Healthcare USD 2.22B 2.12B Dec/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Universal Health Services USD 426.54M 3.78M Mar/2026
Veradigm USD 27.28M 5.24M Dec/2022